- Home
- AIRI vs SCNX Comparison
AIRI vs SCNX Comparison
Compare AIRI & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRI
- SCNX
- Stock Information
- Founded
- AIRI 1979
- SCNX 2010
- Country
- AIRI United States
- SCNX United States
- Employees
- AIRI N/A
- SCNX N/A
- Industry
- AIRI Military/Government/Technical
- SCNX Other Pharmaceuticals
- Sector
- AIRI Industrials
- SCNX Health Care
- Exchange
- AIRI Nasdaq
- SCNX Nasdaq
- Market Cap
- AIRI 13.4M
- SCNX 14.4M
- IPO Year
- AIRI N/A
- SCNX 2020
- Fundamental
- Price
- AIRI $3.38
- SCNX $0.96
- Analyst Decision
- AIRI
- SCNX
- Analyst Count
- AIRI 0
- SCNX 0
- Target Price
- AIRI N/A
- SCNX N/A
- AVG Volume (30 Days)
- AIRI 38.5K
- SCNX 125.4K
- Earning Date
- AIRI 08-13-2025
- SCNX 08-10-2025
- Dividend Yield
- AIRI N/A
- SCNX N/A
- EPS Growth
- AIRI N/A
- SCNX N/A
- EPS
- AIRI N/A
- SCNX N/A
- Revenue
- AIRI $53,182,000.00
- SCNX $146,901.00
- Revenue This Year
- AIRI $5.59
- SCNX N/A
- Revenue Next Year
- AIRI $5.00
- SCNX N/A
- P/E Ratio
- AIRI N/A
- SCNX N/A
- Revenue Growth
- AIRI 0.29
- SCNX N/A
- 52 Week Low
- AIRI $3.00
- SCNX $0.69
- 52 Week High
- AIRI $9.44
- SCNX $23.77
- Technical
- Relative Strength Index (RSI)
- AIRI 46.11
- SCNX N/A
- Support Level
- AIRI $3.31
- SCNX N/A
- Resistance Level
- AIRI $3.72
- SCNX N/A
- Average True Range (ATR)
- AIRI 0.20
- SCNX 0.00
- MACD
- AIRI -0.01
- SCNX 0.00
- Stochastic Oscillator
- AIRI 14.63
- SCNX 0.00
About AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.